This material is needed to produce SIV GP160 DV1 DNA immunogen, that will be used in a macaque SIV vaccine model
Ended Purchase Order Awarded Last action
- Contract number
- 75N91022P00220
- Awardee
-
Aldevron, L.l.c UEI GM49EPBCC4R7 Part of Danaher Corporation
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $16,382
Award facts
- Contract value 100% obligated
- $16,381.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fargo, ND 58104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$28 | |
| Original award | $16,410 |
Quick answers
Who was awarded contract 75N91022P00220?
75N91022P00220 was awarded to Aldevron, L.l.c by National Cancer Institute (National Institutes of Health) on January 26, 2022.
How much is contract 75N91022P00220 worth?
The government has obligated $16,382 on 75N91022P00220.
Was contract 75N91022P00220 competed?
The extent of competition for 75N91022P00220 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award